Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred


IMPACT FACTOR 2017: 3.022

CiteScore 2018: 3.09

SCImago Journal Rank (SJR) 2018: 1.482
Source Normalized Impact per Paper (SNIP) 2018: 0.820

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 384, Issue 3

Issues

Invasiveness of Transformed Human Breast Epithelial Cell Lines Is Related to Cathepsin B and Inhibited by Cysteine Proteinase Inhibitors

A. Bervar / I. Zajc / N. Sever / N. Katunuma / B.F. Sloane / T.T. Lah
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/BC.2003.050

Abstract

The activities of the lysosomal cysteine proteinases cathepsin B and L are regulated by their endogenous inhibitors, stefins A and B, and cystatin C, and their imbalance may be associated with increased invasiveness and development of the malignant cell phenotype. The aim of this study was to investigate mRNA, protein and activity levels of the above proteins in relation to in vitro invasiveness and to the reported in vivo tumorigenicity of four human breast tumor cell lines: the spontaneously immortalized cell line MCF10A, its cHaras transfectant MCF10AT, and two tumorigenic derivative cell lines, MCF10AT-Ca1a and MCF10AT-Ca1d. Invasiveness did not correlate with tumorigenicity, since the MCF10AT cell was the most invasive and the remaining three were at about half of its level. Cathepsin B expression paralleled the in vitro invasiveness through matrigel at all levels of expression, but cathepsin L did not. Stefin levels were elevated severalfold in the tumorigenic cell lines, but not in MCF10AT. The hypothesis that cathepsin B plays an active role in the invasion of breast cancer cell lines was confirmed by the fact that synthetic cysteine proteinase inhibitors, particularly those selective for cathepsin B, significantly reduced the invasion of the MCF10AT cells.

About the article

Published Online: 2005-06-01

Published in Print: 2003-03-14


Citation Information: Biological Chemistry, Volume 384, Issue 3, Pages 447–455, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2003.050.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
M. Trinkaus, A. Vranič, V.V. Dolenc, and T.T. Lah
The International Journal of Biological Markers, 2005, Volume 20, Number 1, Page 50
[2]
Elzbieta Skrzydlewska
World Journal of Gastroenterology, 2005, Volume 11, Number 9, Page 1251
[3]
Eun Kyung Lee, Chan Woo Kim, Hiroyuki Kawanami, Akihiro Kishimura, Takuro Niidome, Takeshi Mori, and Yoshiki Katayama
RSC Adv., 2015, Volume 5, Number 104, Page 85816
[4]
Santhi Maniganda, Vandana Sankar, Jyothi B. Nair, K. G. Raghu, and Kaustabh K. Maiti
Org. Biomol. Chem., 2014, Volume 12, Number 34, Page 6564
[5]
Christopher R. Bohl, Sitaram Harihar, Warren L. Denning, Rahul Sharma, and Danny R. Welch
Journal of Molecular Medicine, 2014, Volume 92, Number 1, Page 13
[6]
Seung Yeon Park, Ji Hyun Bae, and Young Sik Cho
Cell Biochemistry and Function, 2014, Volume 32, Number 3, Page 249
[7]
Bedrich L. Eckhardt, Prudence A. Francis, Belinda S. Parker, and Robin L. Anderson
Nature Reviews Drug Discovery, 2012, Volume 11, Number 6, Page 479
[8]
Boris Gole, Peter C. Huszthy, Mara Popović, Jera Jeruc, Youssef S. Ardebili, Rolf Bjerkvig, and Tamara T. Lah
International Journal of Cancer, 2012, Volume 131, Number 8, Page 1779
[9]
Nataša Obermajer, Petra Kocbek, Urška Repnik, Alenka Kužnik, Mateja Cegnar, Julijana Kristl, and Janko Kos
FEBS Journal, 2007, Volume 274, Number 17, Page 4416
[10]
Vito Turk, Veronika Stoka, Olga Vasiljeva, Miha Renko, Tao Sun, Boris Turk, and Dušan Turk
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2012, Volume 1824, Number 1, Page 68
[11]
Aleš Premzl, Lidija Kovačič, Beata Halassy, and Igor Križaj
Toxicon, 2008, Volume 51, Number 5, Page 754
[12]
Izabela Berdowska
Clinica Chimica Acta, 2004, Volume 342, Number 1-2, Page 41
[13]
Nagathihalli S. Nagaraj and Wolfgang Zacharias
Toxicology Letters, 2007, Volume 170, Number 2, Page 134
[14]
Julia K.L. Woodward, Ingunn Holen, Robert E. Coleman, and David J. Buttle
Bone, 2007, Volume 41, Number 6, Page 912
[15]
Jin-Hyeok Hwang, Sang Hyub Lee, Kwang Hyuck Lee, Keung Youp Lee, Haeryoung Kim, Ji Kon Ryu, Yong Bum Yoon, and Yong-Tae Kim
Cancer Letters, 2009, Volume 273, Number 2, Page 266
[17]
Paul M Campbell and Channing J Der
Seminars in Cancer Biology, 2004, Volume 14, Number 2, Page 105
[18]
Georgie Fear, Slavko Komarnytsky, and Ilya Raskin
Pharmacology & Therapeutics, 2007, Volume 113, Number 2, Page 354
[19]
Claudine Tardy, Patrice Codogno, Hélène Autefage, Thierry Levade, and Nathalie Andrieu-Abadie
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2006, Volume 1765, Number 2, Page 101
[20]
Yasmin Sitabkhan and Allen Frankfater
DNA and Cell Biology, 2007, Volume 26, Number 9, Page 673
[21]
Baogang J. Xu, Wenwei Yan, Bojana Jovanovic, Aubie K. Shaw, Qi A. An, Jimmy Eng, Anna Chytil, Andrew J. Link, and Harold L. Moses
Cancer Microenvironment, 2011, Volume 4, Number 1, Page 61
[22]
Christopher Jedeszko and Bonnie F. Sloane
Biological Chemistry, 2004, Volume 385, Number 11
[24]
Simon Caserman, Saša Kenig, Bonnie F. Sloane, and Tamara T. Lah
Biological Chemistry, 2006, Volume 387, Number 5
[25]
Seung Koo Lee, Myung Shin Han, Subashini Asokan, and Ching-Hsuan Tung
Small, 2011, Volume 7, Number 3, Page 364
[26]
Anil Kumar Agrawal, Godwin Bwire Ekonjo, Elżbieta Teterycz, Dorota Zyoeko, Zygmunt Grzebieniak, Magdalena Milan, Grzegorz Marek, and Maciej Siewiński
Folia Histochemica et Cytobiologica, 2010, Volume 48, Number 3
[27]
Alden H. Warner, Ervin Pullumbi, Reinout Amons, and Liqian Liu
European Journal of Biochemistry, 2004, Volume 271, Number 20, Page 4014
[28]
Boris Gole, María Beatriz Durán Alonso, Vincenc Dolenc, and Tamara Lah
Pathology & Oncology Research, 2009, Volume 15, Number 4, Page 711
[29]
Tamara T Lah, María Beatriz Durán Alonso, and Cornelis JF Van Noorden
Expert Opinion on Biological Therapy, 2006, Volume 6, Number 3, Page 257
[30]
Ashley G Rivenbark, Wendell D Jones, and William B Coleman
Laboratory Investigation, 2006, Volume 86, Number 12, Page 1233
[31]
Agn�s Journet and Myriam Ferro
Mass Spectrometry Reviews, 2004, Volume 23, Number 6, Page 393

Comments (0)

Please log in or register to comment.
Log in